2022YFF1203300/National Key Research and Development Program of China[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2023	1
2024	2
2025	0

Page 1

Dihydroartemisinin restores the immunogenicity and enhances the anticancer immunosurveillance of cisplatin by activating the PERK/eIF2α pathway.

Li Y, Ma P, Li J, Wu F, Guo M, Zhou E, Song S, Wang S, Zhang S, Jin Y. Li Y, et al. Cell Biosci. 2024 Aug 1;14(1):100. doi: 10.1186/s13578-024-01254-0. Cell Biosci. 2024. PMID: 39090653 Free PMC article.

[Opportunities and challenges in accurate early diagnosis and treatment of lung cancer/pulmonary nodules].

Wu F, Yin ZR, Zheng HR, Xu JJ, Yang GH, Jin Y. Wu F, et al. Zhonghua Yi Xue Za Zhi. 2024 May 14;104(18):1547-1554. doi: 10.3760/cma.j.cn112137-20240306-00508. Zhonghua Yi Xue Za Zhi. 2024. PMID: 38742339 Chinese.

Accurate interpretation of p53 immunohistochemical patterns is a surrogate biomarker for TP53 alterations in large B-cell lymphoma.

Li X, Luo D, Zhang L, Li Q, Fan J, Zhang J, Huang B, Yang M, Nie X, Chang X, Pan H. Li X, et al. BMC Cancer. 2023 Oct 19;23(1):1008. doi: 10.1186/s12885-023-11513-x. BMC Cancer. 2023. PMID: 37858047 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year